Phase 3 trial results: orforglopron

Rita summarizes orforglopron's trial showing up to 11% average weight loss at 72 weeks.

Play episode from 01:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!